SERUM ENDOSTATIN LEVEL IS ASSOCIATED WITH POOR SURVIVAL IN PATIENTS WITH ADVANCED STAGES OF HEPATOCELLULAR CARCINOMA - (:unkn) unknown (ELSEVIER SCIENCE BV, 2013)